ES380943A1 - Un procedimiento para preparar una composicion anastesica adecuada para administracion parenteral. - Google Patents

Un procedimiento para preparar una composicion anastesica adecuada para administracion parenteral.

Info

Publication number
ES380943A1
ES380943A1 ES380943A ES380943A ES380943A1 ES 380943 A1 ES380943 A1 ES 380943A1 ES 380943 A ES380943 A ES 380943A ES 380943 A ES380943 A ES 380943A ES 380943 A1 ES380943 A1 ES 380943A1
Authority
ES
Spain
Prior art keywords
solution containing
surfactant
inducing anaesthesia
anaesthesia
inducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES380943A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of ES380943A1 publication Critical patent/ES380943A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES380943A 1969-06-20 1970-06-19 Un procedimiento para preparar una composicion anastesica adecuada para administracion parenteral. Expired ES380943A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3137169 1969-06-20

Publications (1)

Publication Number Publication Date
ES380943A1 true ES380943A1 (es) 1973-07-01

Family

ID=10322106

Family Applications (1)

Application Number Title Priority Date Filing Date
ES380943A Expired ES380943A1 (es) 1969-06-20 1970-06-19 Un procedimiento para preparar una composicion anastesica adecuada para administracion parenteral.

Country Status (19)

Country Link
US (2) US3714352A (es)
JP (1) JPS5140135B1 (es)
AT (2) AT326826B (es)
BE (1) BE752165A (es)
BR (1) BR6915173D0 (es)
CA (1) CA1001073A (es)
CH (1) CH578016A5 (es)
DE (3) DE2030402B2 (es)
DK (1) DK129390B (es)
ES (1) ES380943A1 (es)
FR (2) FR2052998B1 (es)
GB (1) GB1317184A (es)
IE (1) IE35203B1 (es)
IL (1) IL34713A (es)
NL (1) NL169480C (es)
NO (1) NO133716C (es)
PH (1) PH11156A (es)
SE (2) SE406038B (es)
ZA (1) ZA703861B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1376892A (en) * 1970-11-12 1974-12-11 Glaxo Lab Ltd 2beta-substituted-3alpha-hydroxysteroids and their esters
GB1377608A (en) * 1970-12-17 1974-12-18 Glaxo Lab Ltd 3alpha-hydroxy or acyloxy pregnene-21-ethers
US3900561A (en) * 1970-12-17 1975-08-19 Glaxo Lab Ltd Pharmaceutical compositions
GB1377609A (en) * 1970-12-17 1974-12-18 Glaxo Lab Ltd 3alpha-hydroxy-5alpha-pregnane compounds
US3917830A (en) * 1970-12-17 1975-11-04 Glaxo Lab Ltd Steroidal anaesthetic composition for intraveneous injection
GB1430932A (en) * 1972-05-05 1976-04-07 Glaxo Lab Ltd 21-fluoro-pregnanes
GB1436324A (en) * 1972-05-12 1976-05-19 Glaxo Lab Ltd Anaesthetic 3alpha-hydroxy pregnanes
IT1202370B (it) * 1976-07-12 1989-02-09 Hoffmann La Roche Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
IT1204778B (it) 1986-02-04 1989-03-10 Mazzarella Basilio Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale
IE920759A1 (en) * 1991-03-29 1992-10-07 Generali Costruzioni Srl Standardized step module for building prefabricated¹staircases, process for producing such module, prefabricated¹staircase and process for assembling prefabricated¹staircases
CZ300694A3 (en) * 1993-12-02 1996-05-15 Akzo Nobel Nv Substituted 2beta-morpholinandrostane derivatives, process of their preparation, their use for preparing pharmaceutical preparations and pharmaceutical compositions containing thereof
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
WO2005089716A1 (ja) * 2004-03-24 2005-09-29 Takeda Pharmaceutical Company Limited 高含量化製剤
JP7443358B2 (ja) 2018-07-03 2024-03-05 ドローブリッジ ファーマシューティカルズ ピーティーワイ リミテッド 神経活性ステロイドおよび調製の方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1281205A (fr) * 1956-12-21 1962-01-12 Organon Nv Procédé d'obtention de composés de la série du prégnane

Also Published As

Publication number Publication date
GB1317184A (en) 1973-05-16
CH578016A5 (es) 1976-07-30
US3714352A (en) 1973-01-30
DE2065332A1 (de) 1973-04-05
US3781435A (en) 1973-12-25
JPS5140135B1 (es) 1976-11-01
IL34713A0 (en) 1970-08-19
DE2030402C3 (es) 1975-12-11
NL169480B (nl) 1982-02-16
CA1001073A (en) 1976-12-07
DE2030402B2 (de) 1975-04-30
IL34713A (en) 1975-06-25
BR6915173D0 (pt) 1973-02-08
ATA710872A (de) 1975-03-15
IE35203B1 (en) 1975-12-10
SE401512B (sv) 1978-05-16
FR2052998B1 (es) 1974-08-30
DE2065513A1 (de) 1974-04-04
NO133716C (es) 1976-06-16
AT315375B (de) 1974-05-27
NO133716B (es) 1976-03-08
PH11156A (en) 1977-10-28
DK129390B (da) 1974-10-07
FR2052998A1 (es) 1971-04-16
SE406038B (sv) 1979-01-22
FR2052999A1 (es) 1971-04-16
NL7009002A (es) 1970-12-22
IE35203L (en) 1970-12-20
ZA703861B (en) 1971-02-24
DK129390C (es) 1975-02-24
AT326826B (de) 1975-12-29
NL169480C (nl) 1982-07-16
BE752165A (fr) 1970-12-18
DE2030402A1 (de) 1971-01-21
FR2052999B1 (es) 1974-06-14

Similar Documents

Publication Publication Date Title
ES380943A1 (es) Un procedimiento para preparar una composicion anastesica adecuada para administracion parenteral.
SE7416039L (es)
GB1268570A (en) Method for preparing adhesion-improved ethylene-propylene rubber composition
GB739800A (en) Aqueous pharmaceutical solutions of reserpine for parenteral administration
ES372456A1 (es) Procedimiento para la preparacion de un producto de acido graso de mayor estabilidad de sabor.
WU Gestational effect of allylestrenol
ES283585A1 (es) Un procedimiento para la preparación de una composición terapéutica
GB1214712A (en) Contraceptive preparations
GB1029050A (en) Improvements in and relating to new flavone and the process of preparation and application thereof
ES321325A2 (es) Un procedimiento de preparaciën de derivados esteroides
ES287586A1 (es) Un procedimiento para la preparación de una composición terapéutica
GB499715A (en) Adjustable support for shelves
GB806908A (en) Improvements in or relating to new aqueous solutions of monosemicarbazone of adrenochrome
ES395365A1 (es) Procedimiento para la obtencion de agentes anticonceptivos.
ES306376A1 (es) Procedimiento para la preparacion de una composicion farmaceutica.
ES349900A1 (es) Un procedimiento para la preparacion de composiciones far- maceuticas de esteroides clorosustituidos.
FR2074736A1 (en) Choline dehydrocholate - for treating hepatic and biliary disorders
ES350825A1 (es) Procedimiento para la preparacion de 2-azidoacetofenonoxima.
GB807328A (en) Parasiticide composition containing 2, 6-dicyclohexyl-p-cresol
FR2103006A6 (en) Choline dehydrocholate - for treating hepatic and biliary disorders
ES361606A1 (es) Procedimiento para la preparacion de nuevos derivados 5-ni-trofurilicos.
ES355740A1 (es) Un metodo de obtener nuevos derivados de espiro-azatetrame-tileno.
GB816040A (en) Improvements in or relating to therapeutically useful compositions containing reserpine
GB933565A (en) N-isopropyl-n-benzyl-hydrazine
ES383319A1 (es) Un procedimiento para la preparacion de derivados esteroi- dales terapeuticamente importantes y nuevos compuestos in- termedios utiles en este procedimiento.